Literature DB >> 8454596

Phosphorylase kinase phosphorylates the calmodulin-binding regulatory regions of neuronal tissue-specific proteins B-50 (GAP-43) and neurogranin.

H K Paudel1, H Zwiers, J H Wang.   

Abstract

Neuronal tissue-specific proteins B-50 (GAP-43, neuromodulin) and neurogranin are phosphorylated by phosphorylase kinase with stoichiometries of 0.4 and 0.5 mol of phosphate/mol of protein, respectively. The apparent Km and kcat values determined at pH 8.2 for neurogranin phosphorylation are 28.4 microM and 139.3 min-1, respectively, and for B-50 phosphorylation are 22.8 microM and 33.2 min-1, respectively. As a substrate of phosphorylase kinase, phosphorylase is approximately 44 and approximately 13 times better than B-50 and neurogranin, respectively. Both proteins are better substrates of protein kinase C than of phosphorylase kinase and are phosphorylated on a single site by phosphorylase kinase. The sequence analyses of tryptic phosphopeptides isolated from neurogranin and B-50 phosphorylated by phosphorylase kinase revealed the same amino acid sequence, IQASF, indicating that phosphorylase kinase phosphorylates the calmodulin-binding regulatory regions of B-50 and neurogranin previously known to be phosphorylated by protein kinase C (Coggins, P. J., and Zwiers, H. (1989) J. Neurochem. 53, 1895-1901; Baudier, J., Deloulme, J. C., Dorsselaer, A. V., Black, D., and Matthes, W. D. (1991) J. Biol. Chem. 266, 229-237). In rat brain synaptosomes, a relatively high phosphorylase kinase specific activity is detected, and approximately 32% activity is associated with synaptic membranes where B-50 is localized. In rat brain homogenate and synaptosomal membranes, phosphorylation of a protein that co-migrates with B-50 on SDS-polyacrylamide gel electrophoresis is enhanced in the presence of exogenous phosphorylase kinase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454596

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Phosphorylation of GAP-43 (growth-associated protein of 43 kDa) by conventional, novel and atypical isotypes of the protein kinase C gene family: differences between oligopeptide and polypeptide phosphorylation.

Authors:  S A Oehrlein; P J Parker; T Herget
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Pcp4l1 contains an auto-inhibitory element that prevents its IQ motif from binding to calmodulin.

Authors:  Marc A J Morgan; James I Morgan
Journal:  J Neurochem       Date:  2012-04-27       Impact factor: 5.372

Review 3.  RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes.

Authors:  D D Gerendasy; J G Sutcliffe
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

4.  Neurogranin-like immunoreactivity in the zebrafish brain during development.

Authors:  Anabel Alba-González; Julián Yáñez; Ramón Anadón; Mónica Folgueira
Journal:  Brain Struct Funct       Date:  2022-08-26       Impact factor: 3.748

5.  The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.

Authors:  E D Lowe; M E Noble; V T Skamnaki; N G Oikonomakos; D J Owen; L N Johnson
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

6.  Complex formation between gamma-immunoglobulin and calmodulin in calcium-free conditions.

Authors:  Y Takeuchi; P J Birckbichler; M K Patterson
Journal:  Experientia       Date:  1995-04-15

7.  Evidence for multisite ADP-ribosylation of neuronal phosphoprotein B-50/GAP-43.

Authors:  K Philibert; H Zwiers
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

8.  In Silico characterization of phosphorylase kinase: evidence for an alternate intronic polyadenylation site in PHKG1.

Authors:  Joni S Winchester; Eric C Rouchka; Naomi S Rowland; Nancy A Rice
Journal:  Mol Genet Metab       Date:  2007-08-09       Impact factor: 4.797

Review 9.  The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer's Disease.

Authors:  Joana Poejo; Jairo Salazar; Ana M Mata; Carlos Gutierrez-Merino
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.